EIDD-2801, also known as Molnupiravir, is an antiviral drug developed for the treatment of viral infections, particularly those caused by RNA viruses.
EIDD-2801 is a small molecule antiviral drug with a chemical structure that enables it to interfere with the replication process of RNA viruses. It is a prodrug, meaning it is metabolized in the body into its active form, which then exerts its antiviral effects.
The primary mechanism of action of EIDD-2801 involves inhibiting viral replication by inducing lethal mutations in the genetic material of the virus. Once metabolized into its active form, EIDD-2801 mimics one of the building blocks of RNA. When the virus attempts to replicate its genetic material using EIDD-2801, it introduces errors into its RNA sequence, leading to nonviable or less infectious viral progeny. This disruption of viral replication ultimately hampers the virus's ability to spread and cause infection.
EIDD-2801 has demonstrated broad-spectrum activity against a wide range of RNA viruses, including influenza viruses, coronaviruses (such as SARS-CoV-2), respiratory syncytial virus (RSV), and others. This broad activity makes it a promising candidate for the treatment of various viral infections.
| Technical Parameter | Value |
|---|---|
| Generic Name | EIDD-2801 (2349386-89-4) |
| Indication | Treatment of COVID-19 (Cat FIP Treatment) |
| Country of Origin | China |
| Shipping Method | Air (UPS, FedEx, TNT, EMS) or Sea |
| Shelf Life | 2 years |
| Purity | 99% |
| CAS | 2349386-89-4 |
| COA | Available |
| Molecular Weight | 329.31 g/mol |
Function:
Molnupiravir gained significant attention during the COVID-19 pandemic as a potential oral antiviral treatment for SARS-CoV-2, the virus that causes COVID-19. Clinical trials have been conducted to evaluate its efficacy and safety in COVID-19 patients.
Studies have shown that Molnupiravir can reduce the duration of viral shedding and symptoms in COVID-19 patients when administered early in the course of the infection. It is believed to help limit the spread of the virus within the body and potentially reduce the severity of the illness.
1~25kgs packaging: Aluminium bag inside, Carton box outside.
25kgs packaging: Plastic bag inside, Fiber drum outside
